Skip To Main Content
Daniel Wu on Muck Rack

Daniel Wu

Verified
As seen in: The Washington Post, Medium, MSN, MSN Ireland, MSN Singapore, MSN UK, UOL, Estadão, Terra Byte, Yahoo Canada, Yahoo News and
Health reporter @washingtonpost
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Daniel

Contact Daniel, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

FDA approves pancreatic cancer drug that extends patients' lives

|
By Daniel Wu Verified
| MSN Verified
The Food and Drug Administration has approved a new pancreatic cancer drug, a pill that nearly doubled patients' average survival times for one of the deadliest cancers when taken instead of chemotherapy. Researchers have called the drug, known as Rasonque or daraxonrasib and taken daily, a “landmark” development. It has been one of the most closely watched experimental cancer treatments.
Open in Who Shared Issue with article?

FDA approves 'landmark' pancreatic cancer drug that extends patients' lives

|
By Daniel Wu Verified
| MSN Verified
The Food and Drug Administration has approved a new pancreatic cancer drug that nearly doubled patients' average survival times for one of the deadliest cancers, the agency said Wednesday. Researchers have called the drug, known as Rasonque or daraxonrasib, a “landmark” development.
Open in Who Shared View Duplicates (2) Issue with article?

FDA approves ‘landmark’ pancreatic cancer drug that extends patients’ lives

|
By Daniel Wu Verified
| Flipboard
Cancer 1 hour ago FDA approves landmark pancreatic cancer drug that's shown to improve survival Associated Press - By MATTHEW PERRONE and LAURAN NEERGAARD • 1h WASHINGTON (AP) — The Food and Drug Administration on Wednesday approved a groundbreaking new drug for advanced pancreatic cancer, offering U.S. patients a more effective treatment against one of the deadliest types of cancer.
Open in Who Shared Issue with article?
See all 2,055 licensed articles (2,276 Total)